APA citiranje

Khalafallah, A., & Brain, T. (2010). Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia. Università Cattolica del Sacro Cuore.

Citação norma Chicago

Khalafallah, Alhossain, and Terry Brain. Dose-modified Lenalidomide Induces Sustained Hematological Response in Patients With Intermediate to High Risk Myelodysplasia. Università Cattolica del Sacro Cuore, 2010.

MLA citiranje

Khalafallah, Alhossain, and Terry Brain. Dose-modified Lenalidomide Induces Sustained Hematological Response in Patients With Intermediate to High Risk Myelodysplasia. Università Cattolica del Sacro Cuore, 2010.